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Abstract

The formation and storage of memories within the brain remains a subject that is
not well understood. The hippocampus has been identified by many studies as a
likely center for memory formation (Lynch, 2004), and further research into this
subject has begun to suggest that synaptic plasticity in the hippocampus could be
partly responsible for the physical changes in the brain, which underlie memory
formation. Long Term Potentiation is a form of synaptic plasticity, and is
considered to be a physical increase in the strength of connection between
neurons or groups of neurons. Much like memories, the duration of a given LTP
can last anywhere from minutes to years, depending upon the conditions under
which the LTP was induced. Stress, in particular, has been found to either
enhance or impair LTP formation, under different conditions. The brain’s
response to stress, or any kind of emotional arousal, is in part mediated by the
release of the hormone epinephrine. This type of “stress memory”, or
epinephrine-mediated memory formation, is important because it could explain
the pathological memory formation that is commonly seen in phenomena such as
Post Traumatic Stress Disorder (Korol and Gold, 2008). Epinephrine release in
the periphery has been seen to influence LTP in the hippocampus, however
epinephrine itself cannot enter the brain. These experiments served to explore the
mechanisms by which epinephrine can act to bidirectionally influence
hippocampal LTP through activation of β-adrenergic receptors.
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Executive Summary
Memory serves an integral purpose in our lives, yet the mechanisms
underlying memory formation are still not well understood. The hippocampus, a
small structure within the medial temporal lobes of the brain, is considered to be
the center for memory formation. A wide array of clinical and scientific studies
have shown that memory formation is disrupted or prevented altogether when the
hippocampus is not functioning properly. Although memories are not stored in the
hippocampus, per se, this brain structure is crucial to the process by which
memories are formed.
Synaptic plasticity is a phenomenon that occurs throughout the brain.
Plasticity is a broad that describes the unique ability of neurons to change the
strength of their connections to one another over time. Synaptic plasticity is what
allows our brain to adapt and change in response to changes in our environment.
It has been suggested that synaptic plasticity shapes each person’s individual
brain by strengthening the connections that are frequently used, and weakening
those that are not. Long Term Potentiation (LTP) is a form of synaptic plasticity
that can be seen throughout the brain, but has been particularly well studied
within the hippocampus. LTP represents an increase in the strength of connection
between two neurons or groups of neurons. Many studies of LTP are focused on
the hippocampus because LTP is considered to be the cellular mechanism
underlying memory formation, though there are pure technical reasons as well.
Much like memory, the duration of a given LTP can vary greatly, depending on
the conditions under which it was formed. It has been found that stress, in
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particular, can have a significant effect on the formation of LTP in the
hippocampus. The stress response is mediated, in part, by release of the hormone
epinephrine, also known as adrenaline, from the adrenal glands. Epinephrine
release into the blood stream has a variety of effects throughout the body. In
particular, it has been seen that epinephrine can bidirectionally affect LTP by
either enhancing or impairing the formation of LTP within the hippocampus. This
epinephrine-mediated “stress memory” or “emotional memory” is significant
because it could be responsible for the drastic memory dysfunction that is seen in
stress-related conditions such as Post Traumatic Stress Disorder. While it is clear
that epinephrine release in the periphery infuences LTP formation within the
hippocampus, it is unclear exactly how this occurs.
The blood-brain barrier is a highly selective membrane-like covering,
which prevents toxins and unwanted substances that may be circulating in the
blood stream from reaching the brain. The blood-brain barrier is an important
defense mechanism, and acts to allow only small, hydrophobic molecules to enter
the brain. Epinephrine is a relatively large molecule, and as a result is it unable to
pass through the blood-brain barrier. This observation calls to question how
epinephrine can have such a significant effect within the brain, when it is unable
to physically enter the brain. Because epinephrine has been seen to influence LTP,
there must exist some mechanism by which epinephrine release in the periphery is
translated into a signal that can be received by the brain.
It is thought that epinephrine can have an effect on LTP by stimulating the
release of norepinephrine within the brain. Epinephrine release in the periphery
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has been found to cause the vagus nerve to begin firing rapidly. This triggers a
chain of events, which ultimately results in the release of norepinephrine
throughout the brain. Norepinephrine can be released directly into the
hippocampus, where it could potentially bind to receptors and influence LTP.
Alternatively, norepinephrine could also be released into the amygdala. The
amygdala is considered to be the “fear center” of the brain. It comprises a portion
of the limbic system, which is thought of as the source of our most primative,
emotional responses, such as the “fight-or-flight” response. The amygdala, which
rests on top of the hippocampus within the brain, has also been implicated in the
process of memory formation. The amygdala contains a variety of adrenergic
receptors, which are receptors that selectively bind norepinephrine. Importantly,
the basolateral complex of the amygdala (BLA) has many fibers that project to
other brain areas, including the hippocampus, and therefore could act to influence
hippocampal LTP. In addition, the hippocampus proper has β-adrenergic
receptors and may also be the site of LTP modulation by peripheral epinephrine.
This project attempted to discern whether hippocampal or amygdalar regulation
mediated adrenergic control over epinephrine-enhanced hippocampal LTP.
To examine the role of β-adrenergic receptors in epinephrine-enhancement
of LTP, this study used a loss-of-function approach. The β-adrenergic receptor
antagonist, propranolol can be used to selectively block activation of β-adrenergic
receptors within the brain. Under these circumstances, if β-adrenergic receptors
were responsible for mediating epinephrine-enhancement of LTP, it could be
predicted that LTP in the hippocampus would not be enhanced by epinephrine
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while these receptors are blocked. In order to test this, young, male rats were
anesthetized, and stimulating and recording electrodes were implanted within the
hippocampus. These electrodes allow for both the delivery of electrical
stimulation, as well as measurement of LTP in targeted brain areas. Additionally,
each rat was implanted with a cannula, a small tube allowing for direct drug
infusion to the recording site.
LTP in the hippocampus can be recorded as electrical activity within the
brain, which produces a very characteristic pattern known as an extracellular
evoked potential. The strength and durability of any given LTP can then be
measured as variation from an established baseline response. To induce LTP,
these experiments used an established procedure of high-frequency electrical
stimulation (HFS) known to produce LTP within the hippocampus. Before HFS,
rats were randomly separated into test groups based on the drug treatment and
stimulation protocol that they were to receive. Preliminary experiments were
conducted to evaluate the enhancing and inhibiting capabilities of epinephrine
under different dosages and stimulation protocols. Additionally, the effectiveness
of two different doses of epinephrine was tested to determine the dose used for the
main experiment. Within the main experimental group, each test group received a
peripheral injection to the intraperitoneal cavity in the abdomen. Additionally, a
subset of rats also received a local injection via cannula directly to the
hippocampus. Group 1, which was the control group, received injections of
peripheral and local saline; this ensured that there was no effect produced by the
injections themselves. Group 2 received peripheral epinephrine at a dose

vi

previously established to enhance LTP (0.05 mg/kg) as well as a local infusion of
saline; this was the test group for epinephrine enhancement. Group 3, the test
group for adrenergic blockade, received peripheral epinephrine as well as the
local β-adrenergic antagonist, propranolol. This combination should have served
to block the enhancing effect of epinephrine that would be seen with LTP in
group 2. After drug treatments were administered, all groups received HFS, after
which recordings continued to analyze the influence of each drug treatment on
hippocampal LTP formation.
The results of this project showed that, unexpectedly, it could not be fully
demonstrated that epinephrine-enhancement of LTP in the hippocampus was
blocked when β-adrenergic receptors were blocked by propranolol. However, the
main effect observed in the results was that epinephrine does act to bidirectionally
influence hippocampal LTP formation. The mechanisms underlying epinephrinemodulated hippocampal LTP were revealed to be more complex than was initially
thought. Further, it became clear after examining the results that individual
animals could exhibit very different reactions to the same stimulation protocol
and dose of epinephrine. Overall, this led to the conclusion that individual animals
can respond differently to the same stressor, a phenomenon known as the stressresponse phenotype. This stress-response phenotype could have implications for
the broader application to PTSD, as not all individuals who undergo traumatic
experiences will develop this condition. Understanding the mechanisms by which
epinephrine acts to influence LTP in the hippocampus could help illuminate the
larger mechanisms underlying memory formation as a whole. Because memory
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formation under stressful conditions often results in disruptive conditions such as
Post Traumatic Stress Disorder, it is important to understand, in particular, how
stress can act to influence memory formation. The findings of these experiments
are significant because they contribute not only to our knowledge about stress
memory, but also to our understanding of individual differences in memory
formation as a whole.
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Introduction
The mechanisms underlying the formation and storage of memories have
long been a subject of interest to neuroscientists. Experience-dependent changes
in the strength of connections between neurons have been implicated as a
biological mechanism that may underlie long-term memory. Specifically,
persistent increases and decreases in the strength of synapses, known as long term
potentiation (LTP) and long term depression (LTD), respectively, exhibit many
parallels to long-term memory and may play an important role in the storage of
memories (Matynia et al., 2002). LTP is defined as a physiological increase in the
strength of connections between neurons or groups of neurons. This form of
synaptic plasticity occurs throughout the brain, but has been particularly well
studied in the hippocampus. This area of the brain is an ideal electrophysiological
model, as its highly layered structure makes it very easy to study. Further, the
hippocampus has been associated with the processes underlying learning and
memory (Sutherland et al., 2011).
Much like memory, the duration of a given LTP is variable (Malenka et
al., 2004), depending on the conditions under which it was induced. Stress, in
particular, is a condition that has been seen to have a profound impact upon LTP
formation within the hippocampus (Liang et al., 1985; Joels and Krugers, 2007).
Previous studies have identified that the intensity and duration of the stressor
present at the time of memory formation is one factor that can largely impact the
resulting memory (De Boer et al., 1990; Gold, 1989). The stress response is
mediated, in part, by the release of the adrenal hormone epinephrine into the
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bloodstream. It has been found (Maggio and Segal, 2010) that under stressful
conditions, LTP in the hippocampus can be enhanced by the presence of
peripheral epinephrine, however the mechanisms by which this occurs are not
well understood.
Epinephrine is a relatively large, lipophilic molecule that is unable to pass
through the blood-brain barrier. As a result, epinephrine does not directly enter
the brain, yet it has been seen to have a significant effect upon memory formation.
For example, several studies have found that administration of peripheral
epinephrine shortly before a training event can enhance memory for that task
(Gold and van Buskirk, 1976; Gold et al. 1982; McGaugh et al., 1996). In one
particular study, it was found that rats trained on an inhibitory avoidance task,
where a mild foot shock was followed by injection of epinephrine, remembered as
well as rats that were given a much stronger foot shock (Gold, 1989). These and
other studies have extensively demonstrated the enhancing effects, both
behaviorally and electrophysiologically, of epinephrine on memory.
The results of these studies have indicated that epinephrine is capable of
converting a weak memory into a stronger, more durable form. Further, studies
with aged rats (2-years-old) have shown that epinephrine has the ability to prevent
the rapid forgetting that is characteristic in older rats (Gold, 1989; Korol and
Gold, 2008). When trained on the same task, old and young rats are both capable
of learning, however the aged rats generally forget more rapidly.
Memory formation and forgetting are intrinsically linked processes within
the brain. The hippocampus has been used as a model to study these processes, as
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it is thought to play a role in long term information storage (Kuhl et al., 2010).
For example, it has been found that patients with damage to the temporal lobes,
where the hippocampus is located, often experience problems related to memory
formation (Blake et al., 2000). There are parallel studies in animal models
showing that damage to the hippocampus or disruption of its normal function
impairs some types of learning and memory, and leads to more rapid forgetting.
LTP has been implicated as a mechanism by which long term memory
formation could occur or perhaps a model paradigm to demonstrate long term
cellular memory. Particularly, it has been found that when the late phase of
hippocampal LTP is blocked, performance on spatial memory tasks is impaired
(Oikawa, 2012). Furthermore, there are demonstrations that motor memory and
forgetting are tightly correlated to increases and decreases in synaptic strength in
the motor cortex (Rioult-Pedotti et al., 2000). Thus, changes in synaptic strength
may be the general properties of experience-induced brain changes involved in
both memory formation and forgetting. The ability of peripheral epinephrine to
prevent rapid forgetting suggests that epinephrine may also play an important role
in age-related memory loss (Rene, 2008). These findings indicate that epinephrine
is likely to be involved in the cellular mechanisms underlying memory formation,
and could be important for converting new memories into durable, long-lasting
ones.
Epinephrine has the ability to bidirectionally influence memory formation,
acting either to enhance or to impair memory and its correlates (Joels and
Krugers, 2007). Many studies with epinephrine have observed an inverted-U
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relationship between epinephrine and memory (Gold, 1989). In these cases,
intermediate dosages (0.01-0.1 mg/kg) of epinephrine produced enhancement of
memory response, while both higher and lower doses produced no significant
effect (Gold, 1989). This enhancing dose of epinephrine has been seen to both
improve memory retention in training tasks, as well as enhance LTP of evoked
responses within the hippocampus (Gold, 1989, Korol and Gold, 2008). In the
Korol and Gold study (2008), it was found that compared to saline control
treatments, an enhancing dose of epinephrine (0.1 mg/kg) caused LTP in the
hippocampus to be significantly elevated for as long as responses were assessed
(96 hrs). Further, emotional arousal and stress can enhance LTP within the
hippocampus (Tully and Bolshakov, 2010). Emotionally arousing events stimulate
the release of norepinephrine throughout the brain, which can act to lower the
threshold for LTP within the hippocampus (Hu et al., 2007), providing one
possible mechanism for arousal’s actions. Though the enhancing effects of
epinephrine on both LTP and memory is most widely reported, it is important to
emphasize that stress, perhaps through changes in peripheral epinephrine can act
to influence memory formation bidirectionally, impairing and enhancing
retention.
Similar to effects on memory, stress can also either enhance or impair the
formation of hippocampal LTP. For example, the presence of behavioral stress,
such as a foot shock, during training impaired LTP formation in the CA1 region
of the hippocampus (Joels and Krugers, 2007). Further, the Joels and Krugers
(2007) study proposed an alternate mechanism to epinephrine by which stress
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could induce changes in hippocampal LTP involving the release of corticosteroids
in response to stress. Injections of corticosterone, both in vitro and in vivo,
reduced LTP formation within the hippocampus in a dose-dependent manner
(Joels and Krugers, 2007). This effect of corticosterone also followed an invertedU dose-response curve, aligning well with data showing that stress can up-ordown-regulate LTP formation within the hippocampus. However, the ability of
epinephrine to influence both task-related memory and LTP provides a strong
model for understanding the role of epinephrine in modulating memory formation
under emotionally arousing conditions.
Epinephrine plays a major role in the formation of memories during
emotionally arousing events in humans (Cahill and Alkire, 2003). For example,
administration of peripheral epinephrine before a memory test improved memory
in a dose-dependent manner in young adults (Cahill and Alkire, 2003). This
observation has implications for problems such as post-traumatic stress disorder
(PTSD), a condition characterized by persistent and often disturbing memories
that occur after an emotional or traumatic event (Sundin et al., 2010). The
problematic memories that are associated with PTSD are induced under
conditions of high stress, and result in strong memories that are extremely
resistant to decay (Roozendaal et al., 2009). In these circumstances, it is possible
that memory formation could be overly enhanced by the body’s neuroendocrine
stress response. Because epinephrine is capable of converting a transient form of
LTP into a relatively durable one, it is possible that epinephrine could contribute
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to the necessary conditions for the formation of the type of non-decaying
memories that are seen with PTSD (see Korol and Gold, 2008).
Although the influence of epinephrine on memory processing has been
demonstrated by a variety of studies, the mechanism by which it does so remains
unclear. As mentioned above, epinephrine is not readily taken up into the brain,
as it does not cross the blood-brain barrier. However, one possible mechanism is
that epinephrine release in the periphery could result in elevated levels of glucose
within the brain. Recent studies have found that epinephrine may act to enhance
memory by triggering the release of hepatic glucose stores into the blood stream
(Gold and Korol, 2014). Epinephrine release in the periphery can stimulate
hepatic adrenergic receptors, initiating the breakdown of glycogen to glucose,
which is then released into the blood (Sutherland and Rall, 1960). There is a
variety of evidence that supports the idea that the effects of epinephrine on
memory could be mediated by increases in circulating glucose levels (Gold, 1995,
2005, McNay and Gold, 2002, Korol and Gold, 2007). Much like epinephrine,
glucose has been seen to enhance memory in a dose-dependent manner that
follows an inverted-U shaped curve (Korol and Gold, 2008). In fact, changes in
circulating blood glucose levels have been associated with the efficacy of
epinephrine and glucose on enhancing memory. Further, direct infusions of
glucose into specific brain regions are capable of enhancing memory (Ragozzino
et al., 1998, Canal et al., 2005). Alternatively, a different mechanism has been
proposed by which epinephrine release could influence memory.
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Epinephrine can be released into the blood stream from the adrenal
medulla in response to arousal. This neuroendocrine response activates the vagus
nerve, which fires rapidly to activate the locus coerulus neurons of the brain stem,
which in turn stimulate the release of norepinephrine diffusely throughout the
brain (King II and Williams, 2009, Chen and Williams, 2012). As a result, the
release of epinephrine in the periphery ultimately results in the release of
norepinephrine into many areas of the brain, including the hippocampus and
amygdala (Liang et al., 1985). The amygdala is a collection of nuclei that rests in
the medial temporal lobe above the hippocampus. This structure is also
considered to be involved in regulating the effects of stress on memory formation.
For example, animal studies have indicated that both acute and chronic stress can
induce functional changes in specific amygdala nuclei (Roozendaal et al., 2009).
These morphological changes may underlie the behavioral changes that can be
seen in conditions such as PTSD.
Whether arousal acts to modulate neural plasticity through humoral or
circuit processes, it is likely that central adrenergic activation may translate the
peripheral response into a central response. The basolateral complex of the
amygdala (BLA) may play an important role in modulating the effects of stress
upon memory consolidation (McGaugh, 2000). Adrenergic receptors found
throughout the amygdala are capable of binding norepinephrine. Specifically,
stress hormone-induced activation of β-adrenergic receptors (β-ARs) in the BLA
can be associated with enhanced memory for inhibitory avoidance tasks in rats
(Roozendaal et al., 2009). The BLA has been found to influence memory
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formation through its numerous efferent connections to other brain areas. This
interconnectivity could explain the BLA’s role in memory consolidation, as it
contains fibers that both directly and indirectly project to the hippocampus
(Pikkarainen et al., 1999). Similar findings in human studies support these results,
and indicate that both norepinephrine and amygdala activity are required for the
enhanced memory consolidation that often accompanies the stress response
(Cahill et al., 1994, Cahill et al., 1995).
The activation of β-ARs by norepinephrine in the hippocampus is an
attractive mechanism by which epinephrine could act to modulate memory
formation within the brain. β-ARs are cell surface receptors which play an
important role in many areas of the body. These receptors function to activate
adenylyl cyclase via coupling to G-proteins (Liggett, 2000). β-ARs are expressed
throughout the body, and influence critical sympathetic responses in the
cardiovascular, pulmonary, metabolic, and central nervous systems. β-AR
antagonists, commonly referred to as beta-blockers, are capable of effectively
blocking the action of these receptors within the body for a variety of purposes.
Similar to the bidirectional effect of epinephrine on LTP that was
demonstrated in rats (Korol and Gold, 2008), β-AR antagonist action has also
been shown to follow an inverted U-shaped dose-response in smooth muscle
(Calabrese, 2001). This similarity between epinephrine and β-AR action within
the body supports the conclusion that epinephrine could act to influence bodily
processes via β-ARs and adrenergic receptors as a whole. Further, it has been
shown that β-AR activity decreases with age (Tuttle, 1996). If epinephrine does
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act to influence memory formation through activation of β-ARs, this observation
could possibly explain the rapid forgetting that is characteristic in aged subjects.
It is clear that epinephrine is capable of bidirectionally influencing
hippocampal LTP, in a dose-dependent manner, although the mechanisms by
which it does so remain unclear. The stress response, accompanied by the release
of epinephrine in the periphery has a profound impact upon both memory and
LTP. One possibility is that epinephrine activates β-AR in the amygdala, which in
turn modulates hippocampal synaptic plasticity. Another possibility, though not
mutually exclusive, is that β-AR signaling in the hippocampus proper is
responsible for the enhanced LTP. By examining the role of β-AR activation in
the hippocampus, this study has explored the relationship between peripheral
epinephrine and enhancement of LTP within the hippocampus in an attempt to
illuminate the underlying mechanisms. We found that overall, a large amount of
variability exists between individual responses to stress, and the mechanisms
underlying epinephrine-enhancement or impairment of hippocampal LTP are very
complex. Moreover, while developing our stimulation protocols, we found that
the epinephrine dose interacts with the amount of stimulation used to induce LTP
to produce bidirectional modulation of LTP durability, much like the interaction
between arousal level and epinephrine effects on memory formation. These
findings point to important neurochemical events during and after activation that
may play a role in long-lasting synaptic plasticity and information storage.
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Methods
Animals
Young adult male Sprague-Dawley rats, age 3-4 months were used in
these experiments. Rats were housed individually on a 12:12 light-dark cycle,
with ad lib access to food and water throughout the experiment
Surgery
Surgeries were conducted in a manner similar to those outlined in previous
studies (Korol and Gold, 2008). Monopolar stimulating and recording electrodes
were constructed by hand from Teflon-coated stainless steel wire, 114 µm in
diameter. Approximately 1 mm of Teflon coating was stripped from the tip of
each stimulating electrode. Grounding electrodes were constructed from stainless
steel jeweler’s screws soldered to Teflon-coated stainless steel wire. Stainless
steel screws were also used to provide anchorage for the headcap.
Prior to the start of surgery, each rat’s head was shaved and disinfected
with betadine. Each rat was also given a non-steroidal anti-inflammatory and
analgesic drug (Flunixin, 0.001 mg/kg) as well as penicillin (0.0003 mg/kg) prior
to the start of surgery. Before and during surgery, each rat was anesthetized with
isofluorane (induction with 5.0% isofluorane at 500mL/min for approximately 10
minutes, during surgery 250mL/min flow rate with isofluorane between 1.8-4.2%)
for stereotaxic implantation of stimulating and recording electrodes in the medial
perforant pathway (8.1 mm posterior to bregma, 4.2 mm lateral to midline, ~3.5
mm ventral to dura) and hilus of the dentate gyrus (3.5 mm posterior to bregma, 2
mm lateral to midline, ~4 mm ventral to dura), respectively.
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A subset of rats was also implanted with a 6 mm cannula, attached to the
recording electrode, to allow for direct injection of drugs at the recording site.
Under physiological control, the depth of both stimulating and recording
electrodes was adjusted stereotaxically during surgery to maximize the
extracellular evoked potential. Three screws were attached to the surface of the
skull, one on either side of the midline just anterior to bregma, one along the
midline posterior to lambda, and served as anchors for the headcap. An additional
four screws were attached to the surface of the skull, one on either side of the
midline just posterior to bregma, one on either side of the midline at the back of
the skull posterior to lambda. These served as reference electrodes.
All electrode wires were connected to male, gold Amphenol pins. These
pins were inserted into a 9-pin plug that was firmly mounted to the skull using
dental acrylic. Post-surgery, antibacterial ointment (Bacitracin) was applied to the
incision. Analgesic (ibuprofen, 2.35 mL in 500 mL of water) was also given for
24 hours post-surgery to reduce pain. Rats were allowed to rest in their home
cages for one week post-surgery before the start of electrophysiological
recordings.

Electrophysiological Recording
During recording sessions, each rat remained in its home cage, which was
placed inside of a shielded recording chamber. Electrodes in the headcap were
connected via a plug that held the stimulating and recording leads. All leads were
attached to a commutator that was suspended from the frame above the recording
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chamber. This setup allowed the rats to move freely within their home cage
during recordings, and also served to minimize pressure on the headcap.
Recording was performed at the same time daily between the 900 and 1200 hr of
each day (early during the rat’s light cycle) to eliminate any possible confounds
produced by circadian rhythms.
Minimum and maximum stimulation values were determined for each rat
and were used to create an input/output (I/O) curve (Figure 1). Ten stimulation
values were used in the I/O tests. These ranged from an intensity that produced a
threshold field EPSP response (minimum stimulation value) to one at which no
further increase in EPSP slope could be detected (maximum stimulation value).
The eight intervening intensities were generated and were separated by equal
increments. Three test stimulations that were biphasic current pulses of 200 µs
duration were delivered to each perforant pathway every 20 s, alternating between
the left and right hemispheres every 10 s.
I/O functions serve multiple purposes. First, they are used to ensure that
the slope of the EPSP increases linearly in response to increasing stimulation
values to demonstrate that small changes in EPSP can be detected during the
experimental procedure. Input/output functions also served to establish a baseline
stimulation value at 40% of the maximum stimulation in the linear range of the
input/output function, thereby allowing detection of both increases and decreases
in response magnitude. Baseline stimulation intensities ranged from 150 µA to
2mA. Finally, these curves can be used to measure changes in synaptic strength at
intensities other than those used during daily test recordings. Immediately
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following the I/O curve recording, 30 test pulses at baseline stimulation intensity
were delivered to each pathway. Responses to these 30 test pulses were used to
quantify the main dependent measures for analysis throughout the study.
Stimulations and recordings were made with (Signal 4.0, Cambridge
Electronic Design) and delivered with Grass S48 stimulators through constant
current isolation units so any small change in resistance or conductance in the
stimulating electrodes would not produce change in stimulation intensity given to
the perforant pathway. The evoked potentials recorded from the dentate gyrus
were amplified (200-500 times), and filtered (0.3 Hz High pass, 3kHz low pass)
with Grass amplifiers (Model P511K) to allow maximal detection of the synaptic
and action potential component of the field potential responses. Responses were
sampled at 10 kHz by computer, saved and analyzed offline using Matlab
(MathWorks, 2011). Because evoked responses were 10-15 msec in length
(Figure 1A), this sampling frequency provided excellent waveform resolution (10
points/ msec) for quantification.
Daily recordings continued until a stable baseline, defined as < 5% change
in mean response size from day to day could be determined for the evoked
response (typically about 4 days). Once a stable baseline was achieved, the rats
were randomly separated into test groups based upon the drug treatments that
were administered prior to the high-frequency stimulation (HFS) known to
produce LTP.
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Experimental Groups:
Experiment 1: Enhancing and Impairing effects of Epinephrine
Group 1: small HFS-vehicle control
Within this test group (N=6), each rat received a peripheral saline
injection prior to stimulation with a small HFS protocol (one set of ten 400 Hz
trains of five pulses each (1 x 10 x 5)).
Group 2: small HFS- low epinephrine
This group (N=7) received the same small HFS stimulation
protocol (1 x 10 x 5) paired with a peripheral injection of epinephrine at the
enhancing dose (0.01 mg/kg).
Group 3: large HFS-vehicle control
This group (N=9) received a peripheral injection of saline
combined with a larger HFS protocol (two sets of twelve 400 Hz trains of five
pulses each (2 x 12 x 5)).
Group 4: large HFS- moderate epinephrine
This group (N=7) also received the larger stimulation protocol (2 x
12 x 5), as well as a larger dose of peripheral epinephrine (0.1 mg/kg) to
demonstrate the impairing effects of epinephrine under these conditions.
Experiment 2: Dose-dependent influence of epinephrine
Group 1: Moderate HFS- vehicle control
Animals in this control group (N=6) received a peripheral injection
of saline, as well as a moderate stimulation protocol known to produce LTP (one
set of ten 400 Hz trains of ten pulses each (1 x 10 x 10)).
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Group 2: Moderate HFS-moderate epinephrine
This test group (N=8) received the same moderate stimulation
protocol (1 x 10 x 10) as well as an intermediate dose of peripheral epinephrine
(0.1 mg/kg).
Group 3: Moderate HFS- high epinephrine
This test group (N=4) also received the same moderate stimulation
protocol (1 x 10 x 10), in combination with a higher dose of peripheral
epinephrine (0.3 mg/kg)
Experiment 3: Role of β-ARs in mediating epinephrine’s effects on
hippocampal LTP
Group 1: Low HFS- vehicle control (central)- vehicle control (peripheral)
This control group (N=4) received both local (intrahippocampal) as
well as peripheral saline injections, combined with the original stimulation
protocol used in experiment 1 (1 x 10 x 5).
Group 2: Low HFS- vehicle control (central)- low epinephrine (peripheral)
This test group (N=5) received the same stimulation protocol (1 x
10 x 5), as well as a local saline injection. Additionally, animals in this group
received peripheral injections of epinephrine at the enhancing dose (0.01 mg/kg)
in an effort to establish the enhancing effects of epinephrine under these
conditions.
Group 3: Low HFS-propranolol-epinephrine
This test group (N=8) received the same stimulation protocol (1 x 10 x 5)
combined with local injections of propranolol (0.5 µg/µL) and peripheral injection
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of epinephrine at the enhancing dose (0.01 mg/kg). All rats received peripheral
(intraperitoneal) injections prior to HFS, while a subset of rats also received local
(intrahippocampal) injections via a 6 mm cannula ten minutes prior to systemic
injections. This protocol ensured that the β-Adrenergic receptor antagonist had
sufficient time to act upon receptors within the brain before any systemic
injections of epinephrine.
Once all treatments were administered, the rats were allowed to rest in
their home cages for 30 minutes; a post-injection baseline recording was taken
before all groups were given HFS. Three additional recording sessions (I/O and
baseline) followed HFS, after which the rat was returned to the vivarium. Six
hours after HFS, the rat was subjected to one more recording session. After HFS,
daily test recordings continued to evaluate the magnitude of LTP, which gave us a
measure of durability.

Waveform and Data Analysis
Responses were analyzed from all treatment groups, and were evaluated
using two parameters: EPSP slope and magnitude of population spike (Figure
1A). The degree of LTP is often monitored using these parameters because
increases in the slope of the EPSP and magnitude of the population spike reflect
increases in the extracellularly recorded synaptic event and increases in the
number and synchrony of cells firing action potentials, respectively (Taube and
Schwartzkroin, 1988). Changes in these values were extracted from the
waveforms for ten recording sessions: pre-HFS, immediately post-HFS (t0), 20
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minutes post-HFS (t20), 40 minutes post-HFS (t40), 60 minutes post-HFS (t60), 6
hours post-HFS (t6hr), 24 hours post-HFS (t24hr), 48 hours post-HFS (t48hr), 72
hours post-HFS (t72hr), and 96 hours post-HFS (t96hr). Responses were analyzed
based upon overall change in both the slope of the EPSP and the magnitude of the
population spike. Statistical tests were conducted for EPSP slope and PS area
independently to determine if LTP occurred in test groups and if treatment groups
differed across time points throughout the recording session within treatment
groups. Effects of drug injection were also assessed to ensure that there was no
significant change in responses due to the injection itself. Repeated measures
ANOVA were conducted to compare effects within and between test groups.
Significant ANOVA results were followed with post-hoc Dunnett’s test using
baseline values as the control data point.
All procedures were approved by Syracuse University’s IACUC and
followed federak guidelines for the use and care of animals in research.
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Results
In general, the results of this study showed that epinephrine has variable
effects on hippocampal LTP, depending upon the amount of stimulation and dose
of epinephrine. Results from Experiment 1 showed that, compared to saline
controls, a low dose (0.01 mg/kg) of epinephrine combined with a small
stimulation protocol (1 x 10 x 5) enhanced potentiation of the EPSP slope (Figure
2A, B). Conversely, epinephrine at a larger dose (0.1 mg/kg) combined with a
larger stimulation (2 x 12 x 5) blocked potentiation of the slope of the EPSP
(Figure 2C, D). These initial results formed the basis for my independent work as
they indicated that epinephrine, under different conditions, can either enhance
LTP or impair LTP.
In Experiment 2, different dosages of epinephrine were tested under
identical stimulation protocols (1 x 10 x 10) to evaluate the dose-dependency of
the epinephrine response (Figure 3). An intermediate dose of epinephrine (0.1
mg/kg) was capable of enhancing hippocampal LTP, as seen by increases in the
slope of the EPSP. Rats treated with saline exhibited very stable responses, with
no significant potentiation of the EPSP slope occurring during any of the
recording sessions following HFS. Within the intermediate epinephrine group (0.1
mg/kg) LTP was enhanced following HFS, as seen by increases in the slope of the
EPSP, on average. However, while the average data for this group showed a
general enhancement of hippocampal LTP, responses from individual animals
indicated that this dose was capable of either enhancing or impairing hippocampal
LTP. A second, higher dose (0.3 mg/kg) of epinephrine was also tested in this
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experiment. The results from the higher dose of epinephrine fit well with the
established inverted-U dose-response curve. Specifically, there was initial
enhancement immediately afte HFS that seemed to decline at 20 min post-HFS
until 24 hrs later when responses were potentiated again.
Finally, in Experiment 3 rats treated with both local and peripheral saline
showed no increase in the slope of the EPSP any of the time points after low
levels of HFS (Figure 4A). Responses from rats treated with local saline and
peripheral epinephrine at 0.01 mg/kg, the previously established enhancing dose
in rats without cannula, did not show the anticipated enhancement of EPSP slope
(Figure 4B). Although there were subtle increase in the EPSP slope just after
HFS, responses in this group actually became depressed from 20 min to 6 hrs
post-HFS, mirroring the impairing effect that was seen in the 0.3 mg/kg
epinephrine group from Experiment 2. Rats in the group that received both local
propranolol (0.5 µg/µL) and peripheral epinephrine (0.01 mg/kg) demonstrated
stable responses on average, with no significant potentiation of the EPSP slope
visible during any of the recording sessions (Figure 4C).
Because responses across rats seemed variable, we compared two separate
groups of animals that were tested under the same dose of epinephrine (0.01
mg/kg) and stimulation protocol (Figure 5). Group 1(Figure 5A) was tested under
these conditions in Syracuse, while Group 2 (Figure 5B) had been tested
previously in Illinois. Further, rats in Group 1 had been implanted with
intrahippocampal cannulae, which could have served to confound the results.
These results, when compared, show a strikingly different effect of epinephrine.

19

20
Under similar conditions, in separate groups of animals, epinephrine could be
seen to influence hippocampal LTP in very different ways.
While epinephrine did not significantly enhance LTP in these experiments,
upon further examination, an interesting trend became apparent within the
epinephrine test group. Frequently, in the epinephrine group, that the slope of the
EPSP was depressed, compared to its baseline value, in the recording sessions that
immediately followed injections and HFS. However, it was often the case that the
EPSP slope recovered in the later time points. This trend seemed to indicate that
epinephrine actually had an impairing effect upon LTP in the hippocampus in
these rats. Baseline responses for all rats were established to be stable before the
day of HFS, however the results from the day of HFS were somewhat
confounding. A significant decrease in the slope of the EPSP was seen, on
average, from the initial baseline measurement to the post-injection baseline
measurement, indicating that some effect could have been produced by the
injection itself. Overall, when compared to the initial baseline measurement, there
was no significant potentiation of the slope of the EPSP seen at any of the time
points after HFS. As expected, no significant potentiation of the slope of the
EPSP was seen at any time point for the saline control group. When compared
with the saline controls, it appeared as though some slight potentiation occurred in
the epinephrine group at time zero. However, this result was not significant, and
only appeared to be potentiated compared to the depressed response that was seen
with the post-injection baseline.
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While no significant potentiation occurred in either group, closer
examination revealed that there was a difference in responses between the
epinephrine test group and saline controls. LTP responses for the saline group
remained relatively stable at all time points recorded. Animals in the epinephrine
group, however, exhibited a large amount of variability in both the slope of the
EPSP and the magnitude of the population spike. Across all animals in the
epinephrine test group, the slope of the EPSP was depressed, generally from the
t20-t6hr recording sessions, and recovered to around baseline levels in recording
sessions about 24 hours after the initial experiment. Additionally, the overall
waveforms varied greatly for recording sessions following treatment with
epinephrine. Conversely, the slope of the EPSP, magnitude of the population
spike, and overall waveforms remained relatively stable throughout all recording
sessions for the saline group. This effect could be seen in individual rats, as well
as within the groups as a whole. Based on these observations, responses were
grouped into three general categories: epinephrine-enhanced, epinephrineimpaired, and stable responses (Figure 6A, B, and C, respectively). These results,
while unexpected, could serve to provide insight on the bidirectional effect of
epinephrine on hippocampal LTP. The variability that was seen from rat to rat in
these experiments supports the idea that different individuals could respond
differently to stress, a factor that could have served to confound the results.
Overall, the results of these experiments have provided further evidence for the
bidirectional effect of epinephrine upon hippocampal LTP, and could serve to
illuminate the existence of individual differences in response to stress.
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Discussion
Overall, the role of β-ARs in mediating epinephrine’s influence upon
hippocampal LTP could not be determined. It could not be established through
these experiments that epinephrine was capable of significantly enhancing
hippocampal LTP responses at the dose given (0.01 mg/kg), which had previously
been established as an enhancing dose. Instead, the results of this study supported
the idea that epinephrine can act either to enhance or impair the LTP response,
depending on the dose given. The bidirectional effects of epinephrine that were
explored in these experiments could imply that individual responses to the same
stressor can vary greatly, an observation which has implications for the broader
picture of PTSD onset.
It has been established that epinephrine release in the periphery stimulates
the release of norepinephrine in many brain areas, including release into the
hippocampus and amygdala (Gold and van Buskirk, 1978, Miyashita and
Williams, 2004). These experiments explored the possibility that epinephrine in
the periphery could act to influence processes within the brain through
noradrenergic activation of β-ARs in the hippocampus. For the purposes of these
experiments, hippocampal LTP was induced via stimulation to the perforant
pathway, and responses were recorded from neurons in the dentate gyrus. It has
been previously established that the amygdala appears to mediate the formation of
LTP in the dentate gyrus (Frey et al., 2001). Specifically, previous studies have
found that lesions to the BLA reduced overall LTP produced by HFS in the
dentate gyrus (Ikegaya et al., 1995). The BLA, as discussed earlier contains
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afferent fibers that project to many areas of the brain, including the hippocampus.
The interconnectivity of this region could allow the amygdala to exert some
influence upon the formation of LTP within the hippocampus. Similar studies
have demonstrated that lesions to the amygdala also serve to diminish
performance in memory tests, supporting the modulatory role of the amygdala in
memory formation as a whole (McGaugh, 2004). Further, the use of β-ARs to
block adrenoreceptor function inhibited the enhancing effect of epinephrine, and
other hormonal and pharmacological treatments on memory (McGaugh, 2004).
Finally, it has also been shown that β-ARs mediate the modulation of noveltyinduced changes in LTP (Straube and Frey, 2003). Given this evidence, it was
expected that when β-ARs were blocked with the adrenergic receptor antagonist
propranolol (0.5 µg/µL), the enhancing effect of epinephrine on LTP in the
dentate gyrus would also be blocked.
While the results do not show the significant enhancement of LTP by
epinephrine observed in the past, several factors could have served to confound
these results. First, it cannot be demonstrated that no effect was produced due to
the local (intrahippocampal) injections themselves. In the epinephrine test group,
the slope of the EPSP was seen to significantly decrease from the baseline to postinjection time point, indicating that the injection itself may have influenced the
response. Additionally, it is possible that the presence of the 6 mm cannula was
disruptive to the brain tissue, and any injections could have served to further
disrupt function in these areas. Epinephrine was not found to produce enhanced
hippocampal LTP compared to saline controls at any of the time points recorded

23

24
(up to 96 hrs post HFS). However, when compared with the relatively stable
responses in the saline controls, it can be seen that hippocampal LTP responses
were influenced by the presence of peripheral epinephrine. The effective
enhancing dose of epinephrine (0.1 mg/kg) that had been previously established
(Korol and Gold, 2008; Gold et al., 1984) was determined to be too large to be
within the enhancing range for epinephrine in previous trials; therefore a lower
enhancing dose (0.01 mg/kg) was utilized in these experiments. This lower dose
was not confirmed to be capable of significantly enhancing hippocampal LTP
responses by the results of these experiments. Enhancement of these responses
should have been seen by an increase in both the slope of the EPSP and the
magnitude of the population spike, with enhancement lasting as long as 96 hours
post treatment. These primary findings were unable to establish that epinephrine
at the tested dose is capable of producing enhancement of both the magnitude and
duration of hippocampal LTP in rats with cannulae. Due to the difficulty incurred
in producing enhancement of LTP by epinephrine, it was therefore difficult to
assess the enhancing capability of epinephrine, and the mechanisms by which this
could occur. However, the inability to enhance hippocampal LTP with
epinephrine in these experiments served as a basis to explore further the
bidirectional influence that epinephrine has been seen to exert upon hippocampal
LTP formation.
While our experiment could not establish epinephrine-enhancement of
LTP, and therefore could not determine a role for β-ARs, it has been shown that
peripheral epinephrine is capable of enhancing LTP within the hippocampus, and
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further, this enhancement of LTP can be blocked by administration of the β-AR
antagonist, propranolol. These results seem to indicate that β-ARs do play a
significant role in modulating the effects of peripheral epinephrine on
hippocampal LTP. Unfortunately, this effect could not be demonstrated in these
experiments, indicating that there could be other mechanisms at play. In support
of this theory, if peripheral epinephrine does act to induce changes in
hippocampal LTP solely through activation of β-ARs, then it would follow that
activation of these β-ARs should be sufficient to produce enhanced LTP in the
hippocampus. In an earlier phase of this study (results not shown), this hypothesis
was tested using local infusion of the β-AR agonist, clenbuterol. In the absence of
peripheral epinephrine, β-ARs in the hippocampus were activated with
clenbuterol, in the hopes of producing enhancement of hippocampal LTP in a
manner that was consistent with the epinephrine-mediated enhancement of LTP
that had previously been demonstrated. These experiments with clenbuterol
produced some unexpected results. Potentiation that was induced with HFS and
clenbuterol was different from that seen in previous trials in that it produced
significant potentiation of the population spike, but did not significantly potentiate
the slope of the EPSP. This lack of potentiation in the slope of the EPSP suggests
that mechanistic differences could exist between epinephrine-induced and
norepinephrine-induced potentiation, including the possibility that enhancement
of LTP by epinephrine is not mediated entirely by norepinephrine.
Alternatively, there are several sub-types of β-Adrenergic receptors, and
clenbuterol is a β-2 specific adrenergic receptor agonist. It is possible that
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norepinephrine-mediated enhancement of LTP also involves β-1 adrenergic
receptors, which are not activated by clenbuterol. In fact, β-1 adrenergic receptors
have been associated with ERK activation, a protein kinase that could play an
important role in producing long-lasting LTP (Smolen, 2006). Overall, it was seen
that β-adrenergic receptors are at least partly involved in the mediation of
epinephrine-enhancement of LTP and, receptor subtype specificity may determine
the components of the evoked responses that are modulated. Propranolol is a nonselective β-AR antagonist, therefore the blockage of potentiation in both the slope
of the EPSP and magnitude of the population spike that was seen with propranolol
is compatible with the theory that epinephrine enhancement of hippocampal LTP
could be dependent on activation of more than one β-AR subtype. These
differences in β-1 versus β-2 regulation of LTP may point to different cellular and
molecular mechanisms including the signaling pathways and the circuit
characteristics involved in the synaptic plasticity. The results of these
experiments, however, suggest that neurotransmitter systems other than
noradrenergic signaling that could play important roles.
One alternative mechanism by which epinephrine in the periphery could
influence hippocampal LTP formation involves the release of glucose from
hepatic stores. As discussed earlier, epinephrine release in the periphery triggers a
cascade of events, one of which involves the conversion of glycogen to glucose,
followed by release of this hepatic glucose into the blood stream (Sutherland and
Rall, 1960). Further, systemic injections of glucose can act to enhance memory in
a variety of tasks (Korol and Gold, 2007; Gold, 2008, 2014). Glucose can enhance
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memory function in a manner that is very similar to epinephrine, as it also
enhances in a dose-dependent manner, according to an inverted-U dose-response
curve (Korol and Gold, 2008). This alternative theory as to how epinephrine
influences hippocampal LTP could serve to explain some of the results seen in
this study, as noradrenergic activation of β-ARs may not be the only relevant
consequence of peripheral epinephrine release.
As outlined in the results, an intermediate dose of epinephrine (0.1 mg/kg)
often enhanced hippocampal LTP, while a larger dose (0.3 mg/kg) produced
unreliable LTP, which was seeming depressed from 20 mins to 24 hrs post-HFS.
The bidirectional effect of epinephrine that was demonstrated in these
experiments was clearly dose-dependent, following the inverted-U curve that has
been established for epinephrine (Gold, 1989). Additionally, the intermediate dose
(0.1 mg/kg), which was expected to be enhancing, could impair LTP formation in
certain cases. Based on these results, it was hypothesized that the range at which
epinephrine acts to enhance hippocampal LTP is very small (0.01-0.1 mg/kg).
Further, in these cases where the 0.1 mg/kg dose acted to impair LTP, it is likely
that endogenous stress levels at the time of injection created endogenous
epinephrine levels that, when combined with the epinephrine dose injected,
created a very high level of circulating epinephrine that was outside of the
enhancing range. This effect could be accounted for in future studies by
measuring concentrations of epinephrine in the blood stream to determine that the
correct dosage was given.
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The most striking trend that emerged from within the epinephrine test
group results was the incredible variability in the responses. While the saline
responses were seen to remain stable throughout, animals that were given the
same dose of epinephrine could be seen to have entirely different responses. This
observation supports the hypothesis that individual differences in stress response
exist between different subjects.
The stress response triggers a cascade of events within the body, involving
both the locus coeruleus-norepinephrine system, which has been studied here, and
the corticotrophin releasing hormone system (Ellis et al., 2006). These two
functionally integrated circuits interact with one another to mediate the stress
response in each individual. It has been theorized that the stress response is not a
straight-forward mechanism that acts in the same manner for all individuals, but
rather there are several stress-response phenotypes, which guide development of
stress reactivity (Ellis et al., 2006). In this case, individuals react differently to the
same stressor, due to differences in genetic expression and environmental factors.
For example, it has been found that the level of maternal care received during
development can alter the expression of genes that regulate both behavioral and
physiological responses to stress (Meaney, 2001). Further, it was demonstrated in
a different study that rats can be categorized as either “high responding” or “low
responding” based on their level of stress-induced exploration in a novel
environment (Kabbaj et al., 2000). These phenotypes did not change throughout
the course of the study, further cementing the observation that the stress-response
phenotype is developed early in life, and stems from both genetic and
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environmental factors. This stress-response phenotype has also been shown in
humans. One study, in particular, surveyed women before and after they received
colonoscopies, and found that the level of anxiety measured before the test was a
direct indicator of the severity of emotional reaction that was incurred upon
diagnosis (MacLeod and Hagan, 1991). This model of stress-reaction phenotypes
not only fits well with the variable data that were seen in this experiment, but it
could also have implications for the broader picture of this project, to understand
PTSD. While many people experience PTSD after traumatic life events, it is not a
universal phenomenon. That is, not every person who undergoes a traumatic event
will develop PTSD. The existence of multiple stress-response phenotypes could
explain why, in the case of PTSD, certain individuals are more likely to develop
this condition than others.
The results of these experiments were complex and require further
investigation, but they confirm earlier studies showing that epinephrine does play
a role in modulating both LTP and memory formation. Further, upon examination
of the individual responses, interesting trends became apparent which could
underlie the bidirectional nature of epinephrine’s effect upon hippocampal LTP
formation. Epinephrine has been shown to influence memory according to an
inverted-U dose-response curve (Korol and Gold, 2008). According to this model,
if the injections themselves were particularly stressful to the rats, then endogenous
epinephrine levels could have skewed the results. If the animals were already
experiencing elevated epinephrine levels at the time of injection, then it is very
possible that the dose of epinephrine given was not well controlled. As a result, it

29

30
is possible that under stressful injection conditions, rats could have had higher
levels of peripheral epinephrine than was thought, which could have put them
well beyond the range of the established enhancing dose. Further, the different
stimulation protocols tested could have served to activate different signaling
pathways, resulting in different amounts of norepinephrine release within the
brain.
As a whole, the study of epinephrine-mediated enhancement of LTP is
very significant as this mechanism could play a large role in the pathology of
conditions such as PTSD. While it is difficult to base conclusions on the results of
this study, my findings served to illustrate the bidirectional nature of
epinephrine’s influence on hippocampal LTP. Further work on the mechanisms
underlying this phenomenon could illuminate the role of peripheral epinephrine in
mediating both LTP and memory formation as a whole and in conditions where
stress interacts with memory and other aspects of brain function to impair optimal
performance.
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Appendix:
Figure Legends:
Figure 1. Characterization of the evoked response. A) Typical evoked response
shows the change in voltage over time after stimulation B) Input/Output function:
the magnitude of the evoked response varies in accordance with increasing
stimulation input. C) Typical change in evoked response that was seen following
HFS that produced significant potentiation. Note the increased slope of EPSP and
magnitude of population spike following HFS (Red) as compared to baseline
(black).

Figure 2. Epinephrine modulates LTP under different stimulation protocols. A)
No potentiation of EPSP with saline and small stimulation protocol. B)
Enhancement of potentiation with small dose of EPI and small stimulation. C)
Potentiation of EPSP with saline and large stimulation protocol. D) No
enhancement of EPSP with large dose of EPI and large stimulation.

Figure 3. Average changes in slope of EPSP for EPI and saline treatments. A)
Intermediate dose of EPI (0.1 mg/kg) generally produces potentiation of EPSP
slope B). Large dose of EPI (0.3 mg/kg) does not produce potentiation at all time
points. C) Saline produces stable response.
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Figure 4. Average change in slope of EPSP for EPI, saline, and propranolol + EPI
treatments. A) Treatment with EPI failed to produce enhancement of EPSP seen
in figure 2. B) Treatment with saline produces stable EPSP response. C)
Treatment with propranolol + EPI produces stable EPSP response.

Figure 5. Average effect of EPI (0.01 mg/kg) on different animal groups. A) Data
collected from Syracuse, EPI (0.01 mg/kg) in which rats have cannulae do not
produce significant enhancement of potentiation. B) Previous data collected from
Illinois, in which rats do not have cannulae, EPI (0.01 mg/kg) enhances
potentiation.

Figure 6. Individual examples of EPSP slope that characterize the epinephrineenhanced, epinephrine-impaired, and stable groups. A) Variable effect of
epinephrine (0.1 mg/kg). EPI-enhanced (left) EPI-impaired (right). B)
Epinephrine at high dose (0.3 mg/kg) produces unreliable LTP C) Saline produces
stable response.
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Figures:
Figure 1

Figure 2
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Figure 3

Repeated Measures ANOVA:
Group Effect F(2,16)=1.47
p=0.26
Time Effect F(8,128)=1.95 p=0.058 (approaching significance)
Interaction
F(16,128)=1.34 p=0.18

Figure 4

Repeated Measures ANOVA:
Group Effect F(2,5)=0.25
p=0.79
Time Effect F(9,45)=1.15 p=0.35
Interaction
F(18,45)=1.19 p=0.31
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Figure 5

Figure 6
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